RNA Advisors is a strategic and valuation advisory firm specializing in the life sciences and healthcare technology sectors. Founded in 2015, the company offers advisory services in biopharmaceuticals, diagnostics, medical devices, digital health, and technology. With senior executives who have collectively completed over 1,000 engagements representing well over $100 billion in asset and investment value, RNA Advisors has established itself as a prominent player in the industry. The firm's approach involves leveraging their understanding of capital markets to develop credible portrayals of value, positioning them as rising leaders in forecasting, complex valuation, decision analysis, disputes, and transaction advisory services.
There is no investment information
No recent news or press coverage available for RNA Advisors.